Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) has a MoatMap StockRank of 61/100 based on Quality (52/100), Value (48/100), and Momentum (45/100) factor scores. The current signal is HOLD. Guangzhou Wondfo Biotech is an in-vitro diagnostics player facing intense domestic price competition and regulatory headwinds in China's centralized procurement system.
Guangzhou Wondfo Biotech Co., Ltd. specializes in the research, development, and manufacture of Point-of-Care Testing (POCT) rapid diagnostic reagents and instruments. The company offers a broad product portfolio covering infectious diseases, cardiovascular markers, and toxicology, distributed in over 140 countries. Its competitive moat is established through its rapid product commercialization capabilities and extensive global distribution network.
| Price | $2.77 |
| Market Cap | $1.2B |
| P/E (Forward) | 16.10 |
| Price/Book | 1.57 |
| Return on Equity | -3.0% |
| Return on Invested Capital | -1.5% |
| Debt/Equity | 10.89 |
| Gross Margin | 54.2% |
| Operating Margin | 17.2% |
| Revenue Growth | -27.3% |
| Dividend Yield | 1.4% |
| Free Cash Flow | $3M |
Guangzhou Wondfo Biotech Co.,Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).